Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor

Jianguang Zhang1, Huifang Zheng2, Yong Diao3

  • 1School of Medicine, Huaqiao University, Quanzhou 362021, Fujian, China. 1601116007@hqu.edu.cn.

Insights

Natural killer (NK) cells are key innate immune cells. This review highlights NK-92 and CAR-NK-92 cells for their significant roles and applications in tumor immunotherapy.

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • Natural killer (NK) cells are crucial innate immune cells with rapid cytotoxic capabilities against abnormal and infected cells.
  • Advancements in cell biology have led to the establishment of various NK cell lines for research and therapeutic development.
  • NK-92 cells are a prominent human NK cell line, widely utilized and approved for clinical applications.

Purpose of the Study:

  • To review established human NK cell lines and their biological characteristics.
  • To highlight the therapeutic potential and applications of NK-92 cells in cancer immunotherapy.
  • To discuss the advancements and antitumor effects of chimeric antigen receptor-modified NK-92 (CAR-NK-92) cells.

Main Methods:

  • Literature review of established human NK cell lines.
  • Analysis of biological characteristics of NK cell lines, focusing on NK-92.
  • Examination of preclinical and clinical data on NK-92 and CAR-NK-92 cell applications in tumor immunotherapy.

Main Results:

  • NK-92 cells are a well-characterized and clinically approved NK cell line.
  • CAR-NK-92 cells demonstrate potent antitumor activity, enhancing the therapeutic efficacy of NK cells.
  • Various NK cell lines offer distinct advantages for different research and therapeutic contexts.

Conclusions:

  • NK-92 and CAR-NK-92 cells represent promising tools for advancing tumor immunotherapy.
  • Further research into NK cell line applications can lead to novel cancer treatment strategies.
  • The clinical approval and demonstrated efficacy of NK-92 cells underscore their importance in the field.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
876
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.1K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
7.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K